From the Archives: Inventor Mark Kokoris Debuts Roche’s New SBX Sequencer

About this episode

Mark Kokoris discusses the revolutionary SBX sequencing technology and its implications for genomics.

It was the biggest story in sequencing last year: Mark Kokoris, head of SBX sequencing at Roche and inventor of the technology, joins Mendelspod to talk about how Sequencing by Expansion (SBX) works and why it may redefine the limits of genomics. * 0:00 A long journey inspired by PCR * 7:20 What is sequencing by expansion? * 14:00 On scale and accuracy * 19:40 Multi-omics vision? * 24:40 What will be the killer app? * 30:00 Biggest challenge for launch Kokoris recounts the long path from co-founding Stratos Genomics in 2007 to Roche’s acquisition in 2020, when his team’s “wildly ambitious chemistry” finally found its match in Genia’s high-density nanopore platform. “Our approach to efficiently sequencing DNA,” he explains, “is to not sequence DNA. We rescale the problem—expand the molecule about 50-fold—so we can read it with much higher signal-to-noise.” The result is astonishing speed. Working with the Broad Institute and Boston Children’s Hospital, SBX delivered whole-genome results in under four hours, with the sequencing step itself taking only about 15 minutes. Kokoris attributes the achievement to a confluence of chemistry and compute. SBX’s duplex mode achieves…

People in this episode

Host: Theral Timpson

Guest: Mark Kokoris

Topics covered

• sequencing technology
• genomics
• biotechnology
• innovation
• DNA sequencing
• multi-omics

Keywords

• SBX Sequencer
• Sequencing by Expansion
• genomics
• Roche
• Stratos Genomics
• high-density nanopore
• DNA sequencing
• multi-omics
• accuracy
• speed

Mentioned in this episode

Organizations: Roche, Stratos Genomics, Broad Institute, Boston Children’s Hospital

Products: SBX Sequencer, Sequencing by Expansion (SBX), Genia’s high-density nanopore platform

More episodes of Mendelspod Podcast

• Gary Schroth on Connecting Cellular Behavior to the Transcriptome · June 11, 2026 · 33 min
• Two-Thirds of High-Risk Breast Cancer Patients May Avoid Chemotherapy According to Veracyte Data Presented at ASCO · June 9, 2026 · 27 min
• Building the Diagnostic Layer of Modern Cancer Care with Rita Shaknovich and Karina Kulangara of Agilent · May 29, 2026 · 32 min
• Mapping the Multi-Omic Era with Eric Green of Illumina · May 28, 2026 · 44 min
• Inside Proteomics at Thermo Fisher with Yan Zhang · May 21, 2026 · 5 min
• Separating Epigenetic Signals Improves Early Cancer Detection with Rob Osborne, Biomodal · May 19, 2026 · 23 min